Plain-English translation of NCT07737340 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that will follow 250 people who have just been diagnosed with HIV and 161 people without HIV over five years. Researchers want to understand how HIV and HIV treatment may affect liver health and metabolism, particularly a condition called metabolic-associated fatty liver disease. The study will track changes in your body and liver function over time to identify early warning signs.
People living with HIV are at higher risk for liver disease, but doctors don't fully understand which patients are most at risk or how to prevent it. This study aims to identify the early warning signs and risk factors so that treatment can be improved and complications prevented in the future.
You likely qualify if…
You likely don't qualify if…
You would visit a study clinic at baseline (when you start) and then every 12 months for five years. At each visit, you'll have blood tests, measurements of your weight and height, ultrasound or imaging of your liver, and answer questions about your health, medications, diet, and lifestyle. The visits are the same whether you have HIV or not—the researchers simply want to compare how the two groups change over time.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
Turkey (Türkiye)